Inactivation of SARS-CoV-2 Laboratory Specimens
Elaine Haddock, Friederike Feldmann, W. Lesley Shupert, Heinz Feldmann
Abstract
The burden on diagnostic and research laboratories to provide reliable inactivation for biological specimens to allow for safe downstream processing is high during the coronavirus disease 2019 (COVID-19) pandemic. We provide safety data regarding commonly used chemical and physical inactivation procedures that verify their effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Pandemic2019-20 coronavirus outbreakCoronavirusVirologyMedicineBetacoronavirusSevere acute respiratory syndrome coronavirusDiseaseInfectious disease (medical specialty)PathologyOutbreakSARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchBiomedical and Engineering Education